Posted On: 01/09/2015 10:05:37 AM
Post# of 94186
PPCH Bio-Tech Company with Groundbreaking Technology; Propanc Health Group Has Unique Anti-Metastasic Drug M2 Communications
"M2 PressWIRE"
Propanc Health Group Corp. , a biopharmaceutical company organized in Melbourne, Australia , in 2007, has developed a unique drug for the treatment of many types of cancer specifically targeting the process of metastasis. Targeted therapies for metastatic cancer has long been regarded as an important goal in cancer research, as metastasis is the cause of most cancer-related deaths and as no currently approved cancer therapies target metastasis.
"M2 PressWIRE"
Propanc Health Group Corp. , a biopharmaceutical company organized in Melbourne, Australia , in 2007, has developed a unique drug for the treatment of many types of cancer specifically targeting the process of metastasis. Targeted therapies for metastatic cancer has long been regarded as an important goal in cancer research, as metastasis is the cause of most cancer-related deaths and as no currently approved cancer therapies target metastasis.
(0)
(0)Scroll down for more posts ▼
